ARCHIVES

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

This article is from The Cancer Letter archive.

Vol. 13 No. 19 | May 8, 1987

Download PDF Visit The Full Archive

Related Articles

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

ACS Elects New Volunteer Leaders

November 19, 2010

In Brief: Debbie Mayer Elected ONS President; Cullen, Other NCI Staff Honored By Surgeon General

May 15, 1987

Public Health Service: Scientific Papers Become “Deliverables” In Own RFP

October 3, 1997

In Brief: Michael Friedman to Retire as CEO of City of Hope

March 1, 2013

ECOG Phase III Trial To Test Hormones Vs. Chemotherapy For Prostate Cancer.

July 4, 2003